McIlrath & Eck’s Medifast MED Stock Holding History

McIlrath & Eck’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-47	Closed	-$10K	–	813
2021 Q1	$10K	Sell	47 -46	-49%	-$11K	﹤0.01%	483
2020 Q4	$18K	Buy	+93	New	+$16.4K	0.01%	321

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

McIlrath & Eck's MED Position: Q2 2021 in Review

McIlrath & Eck sold out of Medifast (MED) in Q2 2021, closing a stake of 47 shares — an estimated $10K sold.

McIlrath & Eck first reported a position in MED in Q4 2020 and held it in 2 quarters. The position peaked at $18K in Q4 2020. 301 funds tracked by Wall St. Rank hold MED as of Q2 2021.

McIlrath & Eck reported no remaining Medifast position as of Q2 2021 after selling out during the quarter.
McIlrath & Eck sold 47 Medifast shares in Q2 2021, an estimated $10K.
McIlrath & Eck first reported a position in Medifast in Q4 2020 and held it in 2 quarters.
McIlrath & Eck's Medifast position peaked at $18K in Q4 2020.
301 funds tracked by Wall St. Rank held Medifast as of Q2 2021.

Based on McIlrath & Eck's 13F filing for Q2 2021, filed 9 Aug 2021.